Ionis Pharmaceuticals (NASDAQ:IONS) Receives Buy Rating from Needham & Company LLC
Needham & Company LLC restated their buy rating on shares of Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) in a research report report published on Friday morning, Benzinga reports. Needham & Company LLC currently has a $60.00 price objective on the stock. IONS has been the subject of a number of other research reports. Morgan Stanley […]
More Stories
Landstar (OTCMKTS:LDSR) Hits New 12-Month High – Time to Buy?
Shares of Landstar Inc (OTCMKTS:LDSR – Get Free Report) hit a new 52-week high on Tuesday . The company traded...
Landstar (OTCMKTS:LDSR) Hits New 12-Month High – Time to Buy?
Shares of Landstar Inc (OTCMKTS:LDSR – Get Free Report) hit a new 52-week high on Tuesday . The company traded...
Landstar (OTCMKTS:LDSR) Hits New 12-Month High – Time to Buy?
Shares of Landstar Inc (OTCMKTS:LDSR – Get Free Report) hit a new 52-week high on Tuesday . The company traded...
Fukuoka Financial Group (OTC:FKKFF) Reaches New 12-Month Low – What’s Next?
Fukuoka Financial Group, Inc. (OTC:FKKFF – Get Free Report)’s stock price hit a new 52-week low during trading on Tuesday...
Fukuoka Financial Group (OTC:FKKFF) Reaches New 12-Month Low – What’s Next?
Fukuoka Financial Group, Inc. (OTC:FKKFF – Get Free Report)’s stock price hit a new 52-week low during trading on Tuesday...
Fukuoka Financial Group (OTC:FKKFF) Reaches New 12-Month Low – What’s Next?
Fukuoka Financial Group, Inc. (OTC:FKKFF – Get Free Report)’s stock price hit a new 52-week low during trading on Tuesday...